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Abstract 
Background: The effectiveness of long lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), for malaria 
prevention, have been established in several studies. However, the available evidence about the additional resources 
required for a combined implementation (LLIN + IRS) with respect to the added protection afforded is limited. 
Therefore, the aim of this study was to compare the cost-effectiveness of combined implementation of LLINs and IRS, 
compared with LLINs alone, IRS alone, and routine practice in Ethiopia.
Methods: The study was performed alongside a cluster randomized controlled trial of malaria prevention conducted 
in Adami Tullu district, in Ethiopia, from 2014 to 2016. In addition, literature-based cost-effectiveness analysis—using 
effectiveness information from a systematic review of published articles was conducted. Costing of the interventions 
were done from the providers’ perspective. The health-effect was measured using disability adjusted life years (DALYs) 
averted, and combined with cost information using a Markov life-cycle model. In the base-case analysis, health-effects 
were based on the current trial, and in addition, a scenario analysis was performed based on a literature survey.
Results: The current trial-based analysis showed that routine practice is not less effective and therefore dominates 
both the combined intervention and singleton intervention due to lower costs. The literature-based analysis had 
shown that combined intervention had an incremental cost-effectiveness ratio of USD 1403 per DALY averted, and 
USD 207 per DALY averted was estimated for LLIN alone. In order for the ICER for the combined intervention to be 
within a range of 1 GDP per capita per DALY averted, the annual malaria incidence in the area should be at least 13%, 
and the protective-effectiveness of combined implementation should be at least 53%.
Conclusions: Based on the current trial-based analysis, LLINs and IRS are not cost-effective compared to routine 
practice. However, based on the literature-based analysis, LLIN alone is likely to be cost-effective compared to 3 times 
GDP per capita per DALY averted. The annual malaria probability and protective-effectiveness of combined interven-
tion are key determinants of the cost-effectiveness of the interventions.
Trial registration PACTR201411000882128 (Registered 8 September 2014). http://www.pactr .org/ATMWe b/appma 
nager /atm/atmre gistr y?dar=true&tNo=PACTR 20141 10008 82128 
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Background
Scale up of malaria prevention—mainly with the mass 
distribution of long lasting insecticidal nets (LLINs) and 
indoor residual spraying (IRS) of the interior lining of the 
wall of the houses—have brought a remarkable reduction 
in the global burden of malaria in the last decade [1, 2]. 
Empirically, the effectiveness and the cost-effectiveness 
of both LLINs and IRS, for malaria prevention, are well-
established [3–7]. However, evidence also indicates that 
neither LLIN nor IRS—alone—will be sufficient to reach 
and maintain the interruption of transmission in highly 
malarious regions of Africa [8–10].
In Ethiopia, LLINs and IRS are usually implemented 
separately in different districts or different villages [11, 
12]. While LLINs and IRS in some villages have been 
implemented simultaneously within the same households 
[12–16], little is known about the effect and cost-effec-
tiveness of the combined use of LLINs and IRS [12, 17]. 
Moreover, are the additional costs of the combined inter-
ventions reasonable from a provider’s perspective given 
the combined benefits? [7].
Mathematical models by Yakob et al. [18], Okumu et al. 
[19], and Chitnis et  al. [20] shows that there might be 
some additional protective value by a combined imple-
mentation of LLINs and IRS compared to either of them 
alone. A review of cross-sectional data from 17 different 
countries in sub-Saharan Africa also shows that peo-
ple in households which use both bed-nets and IRS are 
about 36% (95% CI 7%–53%) better protected compared 
to households which only use one of the interventions in 
medium malaria transmission areas [16]. Similarly, stud-
ies from Kenya [21] and Tanzania [22] also report posi-
tive results of combining LLINs and IRS. Kleinschmidt 
et  al. based on literature search and a cross-sectional 
survey from Bioko island of Equatorial Guinea, con-
clude that the increased resource use of the combined 
intervention is justifiable because of additional effective-
ness compared with each intervention alone [23]. On the 
other hand, randomized trials from Benin [24], Gambia 
[25], and Sudan [26] report that there is no added effect 
in the combined implementation, compared with each 
intervention implemented separately.
However, none of those studies estimated the effect at a 
general population level, nor did they attempt to evaluate 
the cost and cost-effectiveness of the interventions. In the 
battle against malaria the need for transparent evidence 
based on randomized controlled trials, which integrates 
robust decision modelling, is critical to allocate scarce 
resources appropriately [27]. Such evidence will be use-
ful to guide the selection of the packages of interven-
tions for malaria elimination programs. Specifically, the 
pressing questions in this line of inquiry are; first, what 
are the additional effects of combining both LLIN and 
IRS compared with singleton interventions or the rou-
tine practice? Second, is the value of added protection 
substantial enough to justify the additional resources (i.e. 
cost) required for a combined implementation? There-
fore, the aim of this study was to compare the cost-effec-
tiveness of combined implementation of IRS and LLIN, 
compared with LLIN alone, IRS alone and routine prac-
tice in Ethiopia.
Methods
Study design and settings
This cost-effectiveness study was conducted alongside a 
cluster randomized controlled trial of malaria preven-
tion, with a 2 × 2 factorial design (MalTrials), which 
compared both the effectiveness, cost, and cost-effective-
ness of combined implementation of universal coverage 
of Long Lasting Insecticidal Nets and Indoor Residual 
Spraying (LLIN + IRS) against universal coverage of LLIN 
alone, IRS alone, and the routine practice [28]. MalTrials 
also has substantial entomological components that com-
pare vector outcomes. Furthermore, to improve external 
validity, this study considers the cost-effectiveness under 
a scenario of varying annual malaria incidence and differ-
ent levels of protective-effectiveness of the interventions 
based on a literature survey.
The trial was conducted in 2014–2016 in Adami Tullu 
(Adami Tullu Judo Kombolcha) district, which has a 
population of about 170 thousand [29]. Adami Tullu is 
located in the heart of the Great Rift Valley. The eleva-
tion of the district ranges from about 1500 to 2300 
meters above sea level, with most of the inhabited villages 
located in the lower parts. The annual mean tempera-
ture ranges from a minimum of 14 °C to a maximum of 
27  °C. Like most places in Ethiopia, the district has two 
rainy seasons, the longer (June to September) and the 
shorter (February to April). However, the rainfall pat-
terns are irregular and this contributes to the variability 
of malaria incidence in the area. Malaria is also one of the 
top causes of outpatient visits and inpatient admission in 
Adami Tullu and surrounding area [30]. The pilot study 
for this trial showed an annual malaria incidence of 24 
per 1000 population at risk in this area [31].
Description of the interventions compared
The detail descriptions of the interventions and the size 
of sample population are provided in the published pro-
tocol [28]. In brief, 44 clusters were included in each 
study arm, and a total of 6071 the universal coverage of 
households with Long Lasting Insecticidal Nets entailed 
each household receiving free LLINs (PermaNet 2.0) in 
October 2014. The distribution of the LLIN was con-
ducted based on the national malaria guideline [32], 
which recommends proportional allocation of bed nets 
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to the size of the household. Health extension workers 
distributed the bed net from health posts. A day before 
the distribution date, all households in these groups were 
mobilized by the administration of the villages (i.e. the 
‘chair-person’ and the manager) to come to the health 
posts for collecting the bed nets, after which the LLIN 
coverage was 99%.
The second intervention was universal coverage of 
households with indoor residual spraying the insecticide 
Propoxur (isopropoxy-phenyl methylcarbamate), which 
is currently considered effective. The spraying was con-
ducted annually in September 2014, July 2015, and July 
2016. On average, the IRS coverage was about 95% for 
each of the three rounds of spraying. We followed the 
national indoor residual spraying operation guideline 
[32]. A 6-day training on spraying operation was given 
for locally recruited 13 spray teams and 4 supervisors. 
The personnel were organized in a teams of four spray-
men, a porter, and squad leaders (health extension work-
ers). The four supervisors were malaria focal persons 
from the district health office. In addition, a community 
sensitization was performed to inform residents about 
safety, purpose, and time of spraying. Nearly 12 houses 
were sprayed by each spray-team per day using a spray 
pump which has an 8-l capacity.
In the combined implementation arms, households 
received LLINs and IRS in parallel with households in the 
individual arms, and therefore had IRS coverage of 95% 
and LLIN coverages of 99%. Finally, in the routine arm, 
neither LLIN distribution nor IRS was implemented by 
either the study project or by the district health office 
within the study period, and the background coverage of 
LLINs and IRS based on the baseline survey was on aver-
age 11%. Table 1 summarises the description of the inter-
ventions and participant population in each of the four 
arms of the trial.
Cost‑effectiveness modelling
We developed a simple malaria transmission model 
(Fig.  1) and populated it with effectiveness and cost 
Table 1 Description of the interventions, combinations of intervention and routine arms
Study arms Number 
of households
Description of the interventions
LLIN alone 1387 Universal coverage of households with LLINs: each household received free LLINs (PermaNet 2.0)—pro-
portional allocation to the household size —99% coverage immediately after distribution (October 
2014)
IRS alone 1526 Universal coverage of households with IRS: using Propoxur (isopropoxy-phenyl methylcarbamate) each 
house sprayed once every year—about 95% coverage for each of the three rounds of spraying (Sep-
tember 2014, July 2015, and July 2016)
Combination (LLIN + IRS) 1615 Each household received LLINs and IRS in parallel with households in the individual arms, and therefore 
had IRS coverage of 95% and LLIN coverages of 99%
Routine 1541 Neither LLIN, nor IRS was implemented by either the study project or by the district health office within 
the study period. Based on the baseline data, the background coverage of LLINs was 11%
Fig. 1 a Markov state-transitions diagram, and b Markov tree diagram for the model
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data from the trial. We used TreeAge Pro Suit 2017 (© 
2017 TreeAge Software, Inc.) software for building the 
model and for data analysis. Three mutually exclusive 
health states that represent the dynamics of malaria were 
defined: well (S), death from malaria (Dm), and death 
from all other causes (Da). According to this model, ini-
tially, all individuals are in ‘well’ (S) state, and they all 
are susceptible to malaria. Then, a person from a ‘well’ 
state (S) could be infected and experience a malaria epi-
sode (M) with a certain probability. Once inflicted with 
malaria (M), some could be diagnosed, treated, and 
cured; while some might not be diagnosed and therefore 
remain untreated (Fig. 1). In order to account for ongo-
ing risk, recurrent nature, and short duration of malaria 
illness, we consider malaria episode as ‘temporary states’ 
[33].
In this model, we followed a hypothetical Ethiopian 
birth cohort over their lifetime (i.e. the time horizon 
in this evaluation was 80 years). A similar Markov life-
cycle cohort model was employed for each interven-
tion group (LLIN alone, IRS alone, LLIN + IRS) and 
control group (Routine). Each state was associated 
with annual state rewards, related to spending a year 
in the particular health state. These include the annual 
cost of prevention and the annual effectiveness value: 
DALY averted. Health systems cost of malaria diagnosis 
and treatment, and dis-utility from malaria episode 
were accounted as a transition rewards per event. Both 
the cost and health effect were non-differentially dis-
counted with 3% discount rate.
Transition probabilities were used to capture the 
probabilities of moving from one state to another 
state—within a specific time period called cycle length. 
The cycle length in this model is defined as 1  year. A 
half-cycle correction was done in order to assume that 
events occur half-way through a cycle (rather than at 
the beginning or at the end). We base the transition 
probabilities on primary data (i.e. based on the inci-
dence data from the trial) and a few estimates from the 
World Health Organization (WHO) (Table 2). The most 
likely annual probabilities for malaria were computed 
from the trial result of malaria incidence per 1000 per-
sons year of observation (PYO) which were 15.548 for 
combination, 15.184 for LLINs alone, 15.652 for IRS 
alone, and 15.144 for routine arms. Then, we applied a 
formula, P = 1 − e−rt, in order to convert the incidences 
into transition probabilities using, where P is probabil-
ity, e base of natural logarithm, r is incidence rate, and t 
is time period [34]. The model includes age-specific all-
cause mortality rates (Da) from WHO population life-
table [35], and malaria-specific death rate (Dm) (i.e. 1 
per 100 untreated cases) from WHO estimate [36].
Table 2 Probabilities and costs (2014 USD) used in cost-effectiveness analysis of combined intervention of LLIN and IRS
SD standard deviation, Min minimum value, Max maximum value, GBD Global Burden of Disease study
a The values for Probabilities and DALYs are presented per cycle while Costs and Proportions are presented per event
Parametersa Most likely Min. Max. SD Source
Probability of malaria in combined arm 0.0154 0.0146 0.0162 0.0004 Primary
Probability of malaria in LLIN arm 0.0151 0.0143 0.0159 0.0004 Primary
Probability of malaria in IRS arm 0.0155 0.0147 0.0163 0.0004 Primary
Probability of malaria in routine arm 0.0140 0.0133 0.0147 0.0004 Primary
Proportions of malaria cases tested (%) 90 80 100 0.0500 Primary
Proportions of malaria cases treated (%) 90 80 100 0.0500 Primary
Probability of death from untreated malaria 0.01 0.005 0.02 0.0004 [36]
Intervention cost of LLIN + IRS 4.04 3.00 4.500 0.2020 Primary
Intervention cost of LLIN 1.06 0.848 1.272 0.0530 Primary
Intervention cost of IRS 3.07 2.456 3.684 0.1535 Primary
Intervention cost of routine 0 0 0 0.0000 Primary
Cost of malaria diagnosis at PHCU 0.51 0.408 0.612 0.0255 Primary
Cost of malaria treatment at PHCU 1.17 0.936 1.404 0.0585 Primary
DALY: disability weight-malaria 0.191 0.172 0.211 0.0098 [38]
DALY: disability weight-death 1 1 1 [38]
DALY: disability weight-well 0 0 0 [38]
Discount rate health utility (%) 3 0 5 [40]
Discount rate cost (%) 3 0 5 [40]
Number of cycles (year) 80 10 80 [43]
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Measurement of health effect
The health effect for the trial-based cost-effectiveness 
analysis was entirely based on the randomized controlled 
trial results (Maltrials). We later relaxed this presump-
tion to perform a scenario analysis (literature-based 
cost-effectiveness analysis) on expected values of inci-
dence and effectiveness from literature survey. Using 
the malaria incidence information, disability adjusted 
life years (DALYs) averted was used as a health outcome 
measure in this analysis. The DALYs estimate combines 
the years of life lost (YLL) due to premature death and 
years of life lived with disability (YLD) [37]. The YLDs 
for malaria infection was calculated using standard dis-
ability weights (Table 2) [38]. Since a DALY is a negative 
measure (which we aim to reduce), we inverted the incre-
mental effects when presenting cost-effectiveness results 
to get correct ranking of the alternatives. Death due to 
treated uncomplicated malaria is very rare and assume 
zero mortality. Uncomplicated malaria might progress to 
severe malaria if untreated, and we, therefore, assume a 
mortality of 1 per 100 for untreated cases [36].
In order to estimate malaria incidence, both active 
and passive malaria case detection methods were imple-
mented intensively in four study arms. Every house-
hold was visited every week and asked if there was any 
household member who had a fever in the last 48 h. All 
febrile cases were then tested with a rapid diagnostic test 
(RDT) and blood slides were collected for confirmatory 
diagnosis.
Measurement of intervention costs
Identification, measurement, and valuation of the cost of 
the intervention and cost of malaria diagnosis and treat-
ment was conducted from providers’ perspective [27]. 
The costing of prevention interventions was conducted 
along-side the implementation of indoor residual spray-
ing and the distribution of LLINs using ingredient cost-
ing approach.
Identification
All costs related to the undertaking or facilitation of the 
research activities were excluded. For LLINs, the pur-
chasing cost of the bed nets (LLINs), shipment, customs 
clearance, and transportation fee to the project imple-
mentation district were included in the analysis. Moreo-
ver, at the project site, cost of transportation including 
payments for loading and unloading of the nets, rent fee 
for storage space, stationary materials for orientation 
training and data registration cost were included. On 
the dates of distribution, personnel cost and transpor-
tation cost of the bed nets to each of the villages were 
included. For the IRS, cost of the insecticide (Propoxur), 
spraying materials, equipment, storage, personnel, and 
other operating expenditures used for the indoor residual 
spraying were accounted.
Measurement
Cost data were collected prospectively, immediately 
starting from the beginning of the trial using financial 
expenditure records (invoices) from the project account-
ant services of the implementation of the interventions 
and from the district health office. We used a spreadsheet 
to record cost information. The types and quantity of 
each resource used in the intervention were registered.
We captured the economic costs of the interventions, 
whether they incurred a financial expenditure or not. For 
example, the time spent by health personnel involved in 
prevention or treating malaria was accounted, despite 
that their salaries were already covered by health ser-
vices. While they did not receive additional salaries for 
the specific malaria intervention being evaluated in the 
trial, they could have spent their time on other activities 
representing opportunity costs.
Valuation
In order to identify the economic value of the resources 
used, we used the purchasing price for most of the mate-
rials and equipment, including for the bed nets and the 
insecticides. For items where the price was not known 
from the invoice or the available records, we use esti-
mated values for the items from market inventory data. 
Cost items were divided into recurrent and capital costs. 
Recurrent costs were defined as costs which are incurred 
regularly and with duration of less than a year. Capital 
costs were defined as items, expected to last longer than 
1  year [27]. Capital costs were annuitized based on the 
useful life-year, initial unit price, and interest rate of 6% 
[39]. For example, LLIN costs were assumed to be effec-
tive for 2 years, and hence the purchase cost was annual-
ized over this period.
We valued personnel cost based on an estimated pro-
portion of working-time spent for malaria prevention 
intervention for permanently employed staff. The health 
center heads, malaria focal persons, district health office 
head, district health office deputy head, zonal health desk 
malaria coordinator, store keepers, casher, and guard 
spent about 10% of their time for the IRS or LLINs dis-
tribution during the intervention days; while the health 
extension workers, health centre heads, and malaria focal 
persons spent about 50% of their time for the interven-
tions. This information were used as allocation factors for 
the per-dime and salary rates. However, the spray-men 
and porters, who were temporary staffs and fully dedi-
cated for the interventions during the implementation 
period, all per diem and salary costs were allocated to the 
interventions.
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Unit costs were calculated by dividing the total cost of 
the intervention for the total population covered with 
the specific interventions. All costs were converted to 
USD using the official National Bank of Ethiopia aver-
age exchange rate for 2014 (USD 1 = ETB 20.1). We used 
a consumer price index in order to account for annual 
inflation. The reference year for all cost estimates in this 
study is 2014 USD.
For costs in the routine arms, we only accounted the 
cost of case diagnosis and treatment of malaria in the 
health facilities (health posts and health centre). We used 
Microsoft Excel (2016) for compilation and analysis of 
the cost data.
Measurement of diagnosis and treatment cost of malaria
A combination of top-down and activity-based costing 
techniques was applied in order to track all cost items. 
Using Excel spreadsheet, we systematically extract data 
on expenses for testing and treating a case of malaria 
from the providers’ perspective. Primary cost data on 
diagnosis and treatment of malaria were collected from 
the same district where the trial was conducted, but from 
Primary Health Care Units (PHCU) which were not 
included in the study area. The data was collected from 9 
Health Posts, 3 Health Centres, the District Health Office 
(Adami Tullu), Oromia Regional Health Bureau, and Fed-
eral Ministry of Health Pharmaceuticals Funds and Sup-
ply Agency (PFSA).
Personnel cost includes the cost of health professionals’ 
time involved in treating malaria. The average time spent 
on diagnosis and treatment of a case of malaria was com-
bined with the apportioned net monetary value of the 
personnel time to estimate the personnel cost. At Health 
Centres, Health Officers, Nurses, Laboratory Techni-
cians, and other administrative staffs were involved in the 
diagnosis and treatment of malaria cases, while only the 
Health Extension Workers were involved at Health Posts. 
We divided the entire treatment process into a set of 
activities along the clinical pathway and allocated mon-
etary values for the drug and other supplies consumed 
for each activity. Finally, all cost were converted to 2014 
USD.
Cost‑effectiveness analysis (CEA)
Incremental cost-effectiveness ratio (ICER), cost-effec-
tiveness scatterplot, and cost-effectiveness acceptability 
curve were used to summarize and present the cost-
effectiveness result [27]. The expected costs and health 
outcomes (DALY averted) were calculated for each of 
the four alternative options. We ranked all interventions 
in ascending order in terms of cost of interventions, and 
each intervention was therefore compared with the next 
costly intervention to calculate the incremental costs, the 
incremental effectiveness, and the incremental cost-effec-
tiveness ratio (ICER). We eliminated from comparison 
the interventions that costed more but provided fewer 
benefits than an alternative intervention (dominance).
Based on the economic theory of maximization of 
expected health benefits from the interventions, the 
optimal decision is to choose the strategy with the high-
est ICER per DALY that just falls at or below the will-
ingness to pay (WTP) threshold [40]. In this study we 
applied the WTP threshold suggested by World Health 
Organization’s (WHO’s) Choosing Interventions that are 
Cost-Effective (CHOICE) program that interventions for 
which the ICER per DALY averted is less than one GDP 
per capita as ‘very cost-effective’, between one and three-
times GDP per capita as ‘cost-effective’, and greater than 
three-times GDP per capita as ‘not cost-effective [41]. 
The GDP per capita in Ethiopia for the year 2014 was 
USD 628 [42].
Probabilistic sensitivity analysis
We analysed overall-model uncertainty with probabilistic 
sensitivity analyses (PSA) using Monte Carlo simulation, 
and the results are presented as cost-effectiveness accept-
ability curves, cost-effectiveness acceptability frontiers, 
and scatter plots. In the PSA the variables in the model 
were replaced with distributions. Probabilistic distribu-
tions for costs, dis-utilities, and transition probabilities 
were assigned with most likely (mean), minimum, and 
maximum values. We assumed cost parameters to hold 
gamma distributions, and health outcome and transition 
probabilities to follow beta distributions. We considered 
the minimum and maximum transition probabilities to 
vary ± 5% from the most likely values, and the minimum 
and maximum intervention costs to vary ± 20% from the 
most likely values (Table 2).
Scenario analysis with literature-based 
cost-effectiveness model
The overall incidence of malaria in the study area was 
low during the study period compared with historical 
data and national average estimate [44]. Even though the 
interaction of weather changes and malaria incidence 
is complicated, a likely explanation for such a low inci-
dence, in addition to the intensive intervention of the 
research project, could be the atypical weather during 
the study period. During the years 2015 and 2016, the 
study area was seriously stricken by drought which was 
related to an El Nino event. Meteorological data from the 
study area show that rainfall decreased from 909 mm to 
673  mm during 2011–2014 to 471  mm in 2015. At the 
same time, the average annual high temperature in 2015 
(29 °C) was elevated with 2 °C compared to 2014 (27 °C).
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Furthermore, the trial finding unexpectedly showed 
that the incremental protective effectiveness of either 
the combined intervention or the singleton intervention 
was not significantly different from the routine practice. 
While this result has been observed also in a few other 
studies [17], a majority of the empirical literature con-
cludes that LLIN and IRS have substantial protective-
effectiveness against malaria [17]. While we believe the 
internal validity of these results are good for the timing 
and context of this trial, the generalizability of the effec-
tiveness and cost-effectiveness of combined implementa-
tion of LLIN and IRS are more uncertain.
We therefore performed a literature-based scenario 
analysis of cost-effectiveness for two reasons. First, we 
wanted to reduce a limitation of the trial-based evalua-
tion—poor external validity. Second, we wanted to give 
decision-makers more flexibility to interpret results sub-
ject to a broader set of contexts.
In the literature-based cost-effectiveness analysis, we 
changed the input values from the trial-based analysis for 
malaria risk in the area (annual malaria probability) and 
protective-effectiveness of the interventions. We defined 
annual malaria probability as the probability of acquir-
ing a malaria episode per person within a given year. We 
applied the annual parasitic incidence (API) measured 
as malaria probability per annum per 1000 population at 
risk. The API is the most common and reliable estimate 
of malaria probability in a specified geographic area [45]. 
In Ethiopia, about 17% of the districts on average have 
API lower than 5; and 43% of the districts have 5–100 
API while nearly 7% has API greater than 100 [46]. Nearly 
33% of the district are malaria-free. Based on the World 
Health Observatory data, the average API for Ethiopia 
is 58 per 1000 population at risk in 2015, And therefore 
we assume a base-case annual malaria probability of 5.8% 
(i.e. background malaria risk in the area) [44]. For inter-
vention arms, we multiply the annual malaria probabil-
ity by the protective-effectiveness of the interventions to 
estimate the transition probability in the corresponding 
arms with the presence of the interventions [34].
Regarding effectiveness, we utilised a systematic 
review to assume that the most likely values for protec-
tive effectiveness are 40% (35–45%) for LLINs alone and 
28.5% (23.5–33.5%) for IRS alone [17]. For the combined 
intervention, we calculated protective-effectiveness as 
the multiplicative combination of the individual risk of 
malaria of the singleton interventions (LLIN and IRS) 
[47], yielding a protective-effectiveness of 57%.
One‑way sensitivity analysis
To test the robustness of model conclusion to these 
assumptions, we performed one-way sensitivity analy-
ses on the literature-based cost-effectiveness model, in 
addition to the PSA. We did this for different level of 
protective-effectiveness of the combined interventions 
(47.1–67.1%) and at different level of annual malaria inci-
dence (1–20%), and present results in a tornado diagram, 
where also the variables time horizon, cost, proportion of 
cases diagnosed, proportions of cases treated, probability 
of mortality from severe malaria were included. We eval-
uated the incremental cost-effectiveness values against 
the willingness to pay thresholds of less than or equal to 1 
times GDP per capita.
Results
The results of this paper are organized and presented in 
three parts. First, we describe the cost of the interven-
tions and cost of malaria diagnosis and treatment from 
the providers’ perspective. Second, we present the cost-
effectiveness analysis results based on trial based effec-
tiveness and incidence estimates and cost data from the 
adjunct costing study, and together with probabilistic 
sensitivity analysis findings. Third, we present results 
from the literature-based cost-effectiveness analyses with 
probabilistic sensitivity- and one-way sensitivity analyses.
Cost of interventions
The economic costs of malaria prevention interventions 
from the providers’ perspective are presented in Table 3. 
About 7740 LLINs were distributed with 99% coverage 
within LLIN arm and combination arm for about 3000 
households. The annualized total cost for LLIN arm per 
10,000 population was USD 10,641. About 88% of the 
cost is due to the bed net (LLIN) itself, while only 12% 
was expenditure for the delivery of the intervention (6% 
for personnel and 5% for transportation costs). Therefore, 
the unit cost of LLIN per person year-protected was USD 
1.06. Similarly, with 95% of households covered with IRS 
costs a total of USD 30,660 per 10,000 population. From 
the total cost, about 58% (17,799) was spent for the pur-
chase of the insecticide, and 26% (7883) was for person-
nel. The unit cost of malaria prevention with IRS alone 
per person-year protected was USD 3.07.
In the combined implementation of the interventions 
(LLIN + IRS), USD 40,408 was incurred in order to uni-
versally cover about 10,000 population with both LLIN 
and IRS. In the combined implementation, about 48%, 
22%, and 17% of the cost was attributed to the cost of the 
insecticide (Propoxur), the personnel, and the bed nets 
(LLINs), respectively. The unit cost of combined inter-
vention (LLIN + IRS) per person-year protected was 
USD 4.04 (Table 3).
Unlike the above three intervention arms, in the rou-
tine arm of the study, prevention intervention was imple-
mented neither by the research project nor by the district 
health office. Therefore, the only cost incurred in this 
Page 8 of 17Hailu et al. Cost Eff Resour Alloc           (2018) 16:61 
arm, from the health provider’s perspective, was the cost 
of diagnosis (testing) and treatment of malaria cases. The 
health systems provider’s perspective cost of diagnosis 
and treatment of malaria is presented in Table 4.
Trial‑based cost‑effectiveness results
The trial-based cost-effectiveness results (Table  5) indi-
cate that the routine practice was not less effective than 
the other three alternatives, and therefore strongly domi-
nates them because of lower costs. The expected costs 
from the model were 0.45, 22.16, 63.28, and 83.12 for 
routine practice, LLIN alone, IRS alone, and combined 
interventions, respectively. Combination (LLIN + IRS) 
was about 25% more costly than IRS alone and about 
four times higher than LLIN alone. In terms of expected 
health effectiveness, all the four alternative interventions 
averted almost similar amount of DALYs in a range of 
10.26–10.27 DALYs (Table 5).
The probabilistic sensitivity analysis—the cost-effec-
tiveness scatterplot for the four alternative malaria pre-
vention strategy (Fig. 2)—indicates that the expected cost 
of LLIN alone had less variation and clearly lower than 
the cost of IRS alone
Literature‑based cost‑effectiveness results
The literature-based cost-effectiveness analysis results 
are presented in Table 6. With the modified assumptions 
of intervention effectiveness and malaria incidence, the 
Table 3 Itemised cost of malaria prevention intervention per 10,000 population and unit costs in Adami Tullu, Ethiopia, 
2014 USD
a The unit costs were computed by dividing the ‘annualized total cost’— which was incurred to implement the interventions—with corresponding denominator 
population. The denominators were drawn from the baseline survey
Costs and denominators LLIN (% share) IRS (% share) LLIN + IRS (% share)
Costs of interventions per 10,000 population
 Personnel cost 675 (6) 7883 (26) 8216 (20)
 The bed net cost 9321 (88) NA 9058 (22)
 The insecticide cost NA 17,799 (58) 17,799 (44)
 Materials and supplies 74 (0.7) 2232 (7) 2248 (6)
 Transport costs 527 (5) 1561 (5) 1876 (5)
 Training hall 44 (0.3) 1186 (4) 1211 (3)
 Annualised total cost 10,641 30,660 40,408
Unit  costsa
 Cost per person year protected 1.06 3.07 4.04
 Cost per under-five child year protected 6.98 20.12 26.51
 Cost per pregnant woman year protected 78.67 227.67 298.74
 Cost per household covered 5.49 15.56 20.51
 Total number of household in the study arms 1388 1527 1618
Table 4 Unit cost of  diagnosis and  treatment, and  total cost per  10,000 malaria cases at  primary health care units 
in Adami Tullu, Ethiopia, 2014 USD
Cost of diagnosis and treatment of malaria Unit costs Cost/10,000 cases
Health centre Health post Average
Diagnosis
 Personnel 0.12 0.41 0.26 2600
 Materials and supplies 0.33 0.16 0.25 2500
 Total cost of diagnosis 0.45 0.57 0.51 5100
Treatment
 Personnel 0.09 0.14 0.12 1200
 Drug 1.06 1.06 1.06 10,600
 Total cost of treatment 1.15 1.19 1.18 11,700
 Total cost of diagnosis and treatment 1.60 1.76 1.69 16,800
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expected costs from the model were 1.87, 22.79, 64.09, 
and 83.41 for routine practice, LLIN alone, IRS alone, 
and the combined interventions, respectively. The com-
bination intervention was almost one-third more costly 
than the expected cost of IRS alone (64.09), and about 3.5 
times higher than LLIN alone. In terms of health-effect, 
the routine practice has the highest expected DALYs, 
while the combination of LLIN + IRS averted most 
DALYs and was the most effective of the three active 
alternatives. LLIN averted slightly more DALYs than IRS.
IRS alone was ‘absolutely dominated’ by LLIN alone 
(i.e. IRS alone being more costly but less effective com-
pared to LLIN alone). IRS alone was therefore eliminated 
from further consideration. The model predicts that the 
ICER for combination (LLIN + IRS) was USD 1403 per 
DALY averted compared to LLIN alone, and the ICER for 
LLIN alone was USD 207 per DALY averted compared to 
the routine practice.
Figure  3 shows the cost-effectiveness acceptability 
curves (CEAC) for literature-based CEA of the four 
Table 5 Trial-based cost-effectiveness analysis ICER results, Adami Tullu, Ethiopia
Strategy Cost (USD) Incr cost Eff (DALYs) Incr eff (DALYs averted) ICER
Excluding dominated
 Routine practice 0.5 10.26
All
 Routine practice 0.5 0 10.259 0
 LLIN alone 22.2 21.7 10.264 − 0.005 − 4528
 IRS alone 63.3 62.8 10.266 − 0.007 − 9610
 LLIN + IRS 83.1 82.7 10.265 − 0.006 − 13,546
Fig. 2 Scatterplot of the costs and health-effects of the four malaria prevention alternatives from the Monte Carlo Simulation (100,000 replication)
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malaria prevention alternatives at different levels of will-
ingness to pay per DALY averted. For example, the prob-
ability of combined intervention (LLIN + IRS) being 
cost-effective option was less than 5% at a willingness 
to pay threshold of USD 628 per DALY averted while at 
a willingness to pay threshold of USD 1884 per DALY 
averted (3 times GDP per capita) the probability of the 
combined intervention being cost-effective was about 
70%.
Scenario analysis results of the literature‑based model
Annual malaria probability
In a one-way sensitivity analysis, we tested the effect of 
the background malaria risk on the cost-effectiveness of 
the interventions by varying the annual malaria prob-
ability from 1 to 20% while keeping all other variables at 
their base-case values. The results show that the com-
bined intervention (LLIN + IRS) becomes cost-effective 
compared to LLIN alone when the annual malaria inci-
dence is higher than about 13% if the WTP threshold is 
defined at 1 times GDP per capita per DALY averted. The 
LLIN alone becomes cost-effective compared to the null 
intervention when the malaria incidence is higher than 
about 2% per year (Fig. 4). If we defined the willingness 
to pay threshold at 3 times GDP per capita, the combined 
Table 6 Literature-based cost-effectiveness analysis ICER 
results, Adami Tullu, Ethiopia
Strategy Cost (USD) Incr cost Eff (DALYs) Incr eff 
(DALYs 
averted)
ICER
Excluding dominated
 Routine 
practice
1.9 10.451
 LLIN alone 22.8 20.9 10.350 0.101 207
 LLIN + IRS 83.4 60.6 10.307 0.043 1403
All
 Routine 
practice
1.9 10.451
 LLIN alone 22.8 20.4 10.350 0.101 207
 IRS alone 64.1 41.4 10.379 − 0.029 − 1422
 LLIN + IRS 83.4 60.4 10.301 0.043 1403
Fig. 3 Cost-effectiveness acceptability frontier
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intervention becomes cost-effective in areas where the 
annual malaria probability is higher than 4.5%.
Protective‑effectiveness of the combined intervention
At 5.8% annual malaria probability, the ICER of the 
combined intervention is not likely to be lower than 
GDP per capita when its protective effectiveness is 
varied ± 10% (47.1–67.1%), given that the IRS alone 
reduced the malaria probability by 28.5% and LLIN 
alone by 40%. The protective-effectiveness of combined 
implementation (LLIN + IRS) should be higher than 
53% in order for the ICER to be in a range of 3 times 
GDP per capita per DALY averted (Fig. 5).
Similarly, one-way sensitivity analysis with the Tor-
nado diagrams shows that the ICER of the combined 
intervention in the literature-based analysis was mainly 
sensitive to change in annual malaria incidence in the 
area and the level of protective-effectiveness of com-
bined intervention (Fig.  6). In addition, variability in 
the discount rate of costs and health-effect, and pro-
tective-effectiveness of LLIN alone modestly influenced 
the ICER.
Discussion
This cluster randomised controlled trial found no sig-
nificant difference in the effects of malaria prevention. 
The effectiveness of all the three intervention arms was 
the same as the routine arm, and the economic evalua-
tion inevitably shows that the current routine practice 
dominates all the prevention alternatives since they are 
all more costly. When generalising key inputs from the 
trial and replacing them with literature-based assump-
tions, the economic evaluation shows that both—LLINs 
alone with ICER of USD 207 and the combined inter-
vention with ICER of USD 1403—are likely to be ‘cost-
effective’ compared to a willingness to pay threshold of 
3 times GDP per capita per DALY averted. At a willing-
ness to pay threshold of 1 times GDP per capita, only 
LLIN alone is likely to be cost-effective, while IRS is 
dominated by LLIN (more costly but less effective).
This study is the first of its kind in Ethiopia which 
compared the cost-effectiveness of malaria preven-
tion interventions. Our literature-based analysis yield 
higher ICERs for both the combined intervention and 
LLIN alone compared to previous studies on malaria 
prevention [7]. For example, Goodman et  al. analysing 
Fig. 4 Sensitivity of ICER to variations in the annual malaria incidence in the area
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the cost-effectiveness of malaria in sub-Saharan Africa, 
found an ICER (in 1995 USD per DALY averted) ranging 
only from 32 to 58 for ITN and from 16 to 29 for IRS [48]. 
Another study by Morel et  al. [49] examined the cost-
effectiveness of mixes of curative and preventive inter-
ventions, and reported an ICER (in 2005 international 
dollar per DALY averted) ranging from 10 for case man-
agement with artemisinin-based combination therapy 
to 96 for combination of the four interventions together 
(i.e. IRS, insecticide-treated net (ITN), case management 
with artemisinin-based combination therapy (ACT), and 
intermittent presumptive treatment in pregnancy). A sys-
tematic review of studies published between 2000 and 
2010 [6] reported a median ICER of 27 per DALY (range 
8.15–110) for LLIN/ITN and 143 per DALY (range 135–
150) for IRS.
The relatively high ICERs in this study compared to 
other studies in Africa can be partly explained by the 
differences in malaria burden, the incremental costs of 
interventions, and unique malaria dynamics in Ethio-
pia. In the last 15 years, the incidence of malaria in sub-
Saharan Africa decreased significantly [2, 44, 50], while 
the cost of the interventions increased [51]. The cost of 
the intervention increased mainly because of the replace-
ment of DDT (Dichlorodiphenyltrichloroethane) with 
Propoxur, use of LLINs instead of ITNs, and the intro-
duction of the ACT. All these three recent changes were 
not only associated with improving malaria prevention 
and control, but also with increased cost to the health 
system. Particularly IRS was costly in our study and this 
was mainly caused by the price of the insecticide. In 
theory, although insecticide resistance can be one of the 
factors which can affect the cost-effectiveness of IRS or 
combined intervention, it is less likely that it’s’ effects 
could influence the results in our trial. Our entomo-
logical study indicates that the efficacy of the insecticide 
(Propoxur) applied in all the study arms was similar and 
very potent in all study arms for the whole year [MalTri-
als Final report, Unpublished]. In addition, the differ-
ence in malaria epidemiology in Ethiopia compared with 
other places in African or elsewhere could also largely 
contribute to this disparity [52]. The epidemiologic pro-
file of malaria in Ethiopia is in a number of ways different 
compare to other African countries. For example, malaria 
transmission in Ethiopia is low to moderate, unstable, 
Fig. 5 Sensitivity of ICER to variations in the protective-effectiveness of combined intervention
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and seasonal while it is high, stable, and perineal else-
where [52, 53].
Practically, economic evaluation of malaria preven-
tion interventions is complex [7, 54]. Unlike typical 
cost-effectiveness evaluations, in some cases, the effects 
of combined interventions might be the same with the 
effect of individual interventions alone; and subsequently, 
the incremental effect could be negligible. In other cases, 
any of the intervention might not be effective at all—even 
compared with ‘doing-nothing’ [17]. In our study also we 
found that the effectiveness of the combined intervention 
was the same with both singleton and routine interven-
tions. This might be partly explained by the ‘counter-bal-
anced effect’ between incremental health effect and cost 
saved resulting from adding IRS over high LLIN cover-
age or vice versa. On the other hand, the strong protec-
tive effect from active case finding and treatment by itself 
might dilute the ‘modest’ protective-effects from other 
preventive measures (i.e. LLIN and IRS). It is also impor-
tant to note that in this trial—across all the four study 
arms—a weekly visit to each household was conducted 
in order to identify any febrile member of the household, 
and almost all febrile cases were tested with RDT, and if 
found positive, treated with the appropriate ant-malaria 
drug [28]. Therefore, we strongly recommend further 
pragmatic trials from different setting from our study to 
estimate protective-effectiveness of the intervention.
In general, the cost-effectiveness of malaria prevention 
intervention is a function of the health benefit gained and 
the resources required to implement the intervention 
[27]. In the one-way sensitivity analysis, first, we tested 
the effect of the background malaria incidence in the area 
on the cost-effectiveness of the interventions by varying 
the annual probability of malaria infection for an individ-
ual from 1 to 20%. On account of this, the ICER for com-
bined intervention varied from about USD 8000 to USD 
200 per DALY averted. Moreover, the annual malaria 
incidence should be at least about 13% in order for the 
combined intervention to be cost-effective compared 
with a willingness to pay threshold of 1 times GDP per 
capita per DALY averted for Ethiopia (USD 628). How-
ever, what the recent data from Ethiopian Ministry of 
Health indicates is that only a few areas in Ethiopia have 
malaria risk levels of such magnitude. Only about 5% of 
Fig. 6 Tornado diagram—ICER LLIN + IRS vs. LLIN only
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the districts in Ethiopia, mostly in Western lowlands and 
few in the Rift Valley, have annual incidence rates exceed-
ing 13% [46], and based on the results of this analysis 
should be the focus of attention for future prevention 
campaigns.
These findings should be interpreted in the light of at 
least two important issues about the dynamics of malaria 
control program at low incidence setting (i.e. at stages 
of elimination and eradication) should look like. First, 
malaria control program should not be a victim of its 
own success [55]. When the malaria control program 
succeeds, malaria incidence will certainly reduce. In this 
case, such a versatile malaria prevention interventions 
like IRS and LLIN will not continue to be sufficiently 
competitive in terms of cost-effectiveness parameter, 
and LLINs and IRS will both appear to be not cost-effec-
tive [55]. Therefore, it has been argued that for malaria 
prevention programs the willingness to pay thresholds 
should be expanded from the conventional level [56]. 
Second, the need for disaggregate malaria data at a dis-
trict level is crucial for better targeting of interventions 
and for local planning (micro-planning). In this regard, 
the National Malaria Control Program in Ethiopia has 
also recently stratified all districts based on annual 
malaria incidence into four groups (i.e. free, low, moder-
ate, and high) and started conducting interventions based 
on the strata [46].
The second parameter that we examined in the one-
way sensitivity analysis was the protective-effectiveness 
of combined intervention. We found that the combined 
intervention (LLIN + IRS) need a minimum of 53% pro-
tective-effectiveness in order to be ‘cost-effective’ alter-
native (Fig. 5). It is important to remember that none of 
the interventions have an inherent degree of effective-
ness. Rather, it is the manner how it is implemented, the 
identification of those areas where it is most suitable, and 
the proper use by the community which determine the 
effectiveness most. However, based on a recent system-
atic review [17], it would be very challenging to achieve 
a protective-effectiveness of such level (53%) against 
the current supply side and demand-side barrier which 
reduces the effectiveness of both individual and com-
bined interventions. The major demand side barriers for 
LLIN, observed in our visits, includes under-utilization, 
misuse, and lack of convenient sleeping space to hang-
up the bed nets; while refusal, covering the wall of the 
house with a mud or other material, and rudimentary 
nature of the wall for some of the houses were challenges 
for IRS. The financial and human capacity of the district 
to execute the interventions, the price of the insecticide, 
and the quality of the LLINs can be considered as major 
supply-side barriers. IRS demands strong and very close 
supervision.
The costing analysis shows that the unit cost of IRS per 
person-year protected was predominantly influenced 
by the price of the insecticide, which alone accounted 
for about sixty percent of the cost. Regarding the cost of 
LLIN, in addition to the price of the bed nets, useful life-
year (durability) of the bed nets was important parame-
ters which determined the cost of LLIN per person-year 
protected. The life-year of the LLINs determines the fre-
quency of the redistribution (refill). In Ethiopia, based 
on the National Malaria Program, LLINs were intended 
to serve for about 3  years and therefore the distribu-
tion campaigns are held once every 3  year [11]. How-
ever, what we observed in our study was that the LLINs 
worn out faster, and had little effect after 1 to 2  years. 
Local production of the bed nets with low cost and better 
quality could reduce the price of the bed nets. A strong 
quality control mechanism in the production, procure-
ment, and distribution of the nets can be considered not 
only to maintain the fabric integrity of the nets but also 
to maintain the insecticidal property. Above all, a well-
coordinated information, education, communication and 
advocacy program promoting proper utilization of the 
LLIN could improve both effectiveness and longevity of 
the LLINs.
In this study, most of the cost items of malaria preven-
tion interventions at the district level were identified, 
measured, and valued prospectively alongside the com-
munity trial using robust techniques [27]. Yet, there are 
some caveats that deserve due consideration with respect 
to the data, generalizability, and relevance of this study. 
The first limitation was that the costing was done only 
from the local providers’ perspective and a few cost items 
incurred at national and regional levels (e.g. mass-media 
and communication costs etc.) were omitted. Although 
this might not have substantial implication when we 
compare the cost and cost-effectiveness of the prevention 
interventions, this might to some extent underestimate 
the actual unit cost of the interventions.
The second limitation to our model was that we were 
not able to account for health-loss from co-morbidities of 
severe malaria such as anaemia, convulsions, and long-
term neurological sequel because of lack of accurate esti-
mates about the magnitude of these events. Despite the 
effect on the ICER would be minimal since the probabil-
ity of severe cases is rare in the cases of treated malaria 
[36], this might underestimate the actual benefit of the 
prevention intervention slightly [57].
A third limitation of this study is in the decision we 
made in choosing 1 times or 3 times GDP per capita 
per DALY averted as a willingness to pay thresholds for 
interpretation of the ICER results. Despite long-stand-
ing debate in economic evaluation literature on this 
issue [58], it is particularly important for the evaluation 
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of malaria prevention interventions in Ethiopia [57]. 
It is difficult to precisely define the WTP threshold in 
Ethiopia due to the fact that the financing of health 
care in general and malaria programs, in particular, are 
complex. For example, the larger share of the funding 
(78.6%) for malaria is generated from different to exter-
nal sources (UNICEF, PMI, GLOBAL FUND, WHO 
etc.) and most of which is also ear-marked for malaria 
(vertical program) [59]. This kinds of cost-effectiveness 
evidence would be most relevant in a country where 
there is functional and established disease control pri-
ority-setting system which utilizes economic evaluation 
in decision making [60].
Conclusions
Based on the current trial-based analysis, LLINs and IRS 
are not cost-effective compared to routine practice. How-
ever, based on the literature-based analysis, LLIN alone 
appear as likely to be cost-effective if willingness to pay 
is defined at 1 times GDP per capita per DALY averted, 
while IRS is dominated by LLIN (i.e. more costly but less 
effective). The annual malaria risk in the area and pro-
tective-effectiveness of combined intervention and LLIN 
are the key determinants of the cost-effectiveness of the 
interventions. Malaria program implementation should 
provide high focus to the improvement of the protective-
effectiveness of IRS and LLIN.
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